Granulocyte colony-stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream.
This report contains market size and forecasts of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs in Global, including the following market information:
Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Filgrastim Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Granulocyte-Colony Stimulating Factor (G-CSF) Drugs include Amgen, Kyowa Kirin, Chugai Pharmaceutical, Novartis, Teva, Pfizer, Merck, Dong-A Socio and Intas, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Granulocyte-Colony Stimulating Factor (G-CSF) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Segment Percentages, by Type, 2021 (%)
Filgrastim
Pefigrastim
Lipefigrastim
Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Segment Percentages, by Application, 2021 (%)
Oncology
Blood Disease
Other
Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Granulocyte-Colony Stimulating Factor (G-CSF) Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Granulocyte-Colony Stimulating Factor (G-CSF) Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Kyowa Kirin
Chugai Pharmaceutical
Novartis
Teva
Pfizer
Merck
Dong-A Socio
Intas
GenSci
Dr. Reddy
Amoytop
North China Pharmaceutical
SL Pharm
Hayao Group